Pancreatic Cancer Research

ResearcherUniversidad San Pablo CEUNo recent work listed

Niki A. Ottenhof

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0004-3713-4747; OpenAlex author ID A5080654497. Sources: OpenAlex.

Their work

Papers
8
Trials
0
Grants
0
Labs led
0
Collaborators
33
Papers, trials and grants by year

2011: 3 papers · 2012: 3 papers · 2013: none · 2014: none · 2015: 2 papers

Papers 8

  1. Proteins associated with pancreatic cancer survival in patients with resectable pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/labinvest.2014.128↗
  2. Very Long-term Survival Following Resection for Pancreatic Cancer Is Not Explained by Commonly Mutated Genes: Results of Whole-Exome Sequencing Analysis. Co-author DOI 10.1158/1078-0432.ccr-14-2600↗
  3. Multivariate analysis of immunohistochemical evaluation of protein expression in pancreatic ductal adenocarcinoma reveals prognostic significance for persisten… Co-author DOI 10.1007/s13402-012-0072-x↗
  4. Pancreatic ductal adenocarcinoma in hereditary diffuse gastric cancer. A case report. Co-author DOI 10.1016/j.humpath.2011.06.008↗
  5. Stromal galectin-1 expression is associated with long-term survival in resectable pancreatic ductal adenocarcinoma. Co-author DOI 10.4161/cbt.20842↗
  6. MK-1775, a potent Wee1 inhibitor, synergizes with gemcitabine to achieve tumor regressions, selectively in p53-deficient pancreatic cancer xenografts. Co-author DOI 10.1158/1078-0432.ccr-10-2580↗
  7. Molecular characteristics of pancreatic ductal adenocarcinoma. Co-author DOI 10.4061/2011/620601↗
  8. Cyclin-dependent kinase inhibitor Dinaciclib (SCH727965) inhibits pancreatic cancer growth and progression in murine xenograft models. Co-author DOI 10.4161/cbt.12.7.16475↗

Closest collaborators

The 25 strongest of 33 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Anirban Maitra · 6 shared papers, 2011–2015 · strength 0.19
  2. Roeland F. de Wilde · 5 shared papers, 2011–2015 · strength 0.18
  3. G. Johan A. Offerhaus · 3 shared papers, 2011–2012 · strength 0.10
  4. Christopher Lee Wolfgang · 2 shared papers, 2015 · strength 0.08
  5. Ralph H. Hruban MD · 2 shared papers, 2011–2015 · strength 0.08
  6. Ru Chen · 2 shared papers, 2012–2015 · strength 0.07
  7. Teresa A. Brentnall · 2 shared papers, 2012–2015 · strength 0.07
  8. Sheng Pan · 2 shared papers, 2012–2015 · strength 0.07
  9. N.V. Rajeshkumar · 2 shared papers, 2011 · strength 0.05
  10. Manuel M. Hidalgo · 2 shared papers, 2011 · strength 0.05
  11. Bert Vogelstein · 1 shared paper, 2015 · strength 0.04
  12. Nickolas Papadopoulos · 1 shared paper, 2015 · strength 0.04
  13. Neda Rezaee · 1 shared paper, 2015 · strength 0.04
  14. Amanda L. Blackford · 1 shared paper, 2015 · strength 0.04
  15. Marco Dal Molin · 1 shared paper, 2015 · strength 0.04
  16. Ming Zhang · 1 shared paper, 2015 · strength 0.04
  17. Kenneth W. Kinzler · 1 shared paper, 2015 · strength 0.04
  18. Laura DeLong Wood · 1 shared paper, 2015 · strength 0.04
  19. Meghna Waghray · 1 shared paper, 2015 · strength 0.04
  20. Diane M. Simeone · 1 shared paper, 2015 · strength 0.04
  21. David W. Dawson · 1 shared paper, 2015 · strength 0.04
  22. Anya N. Milne · 1 shared paper, 2012 · strength 0.03
  23. Hans Morreau · 1 shared paper, 2012 · strength 0.03
  24. Richard van Hillegersberg · 1 shared paper, 2012 · strength 0.03
  25. Christopher L. Wolfgang · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.